Contact dermatitis due to the beta-blocker befunolol [corrected] in eyedrops.
Kanzaki
T
T
Department of Dermatology, Nagoya City University Medical School, Japan.
Kato
N
N
Kabasawa
Y
Y
Mizuno
N
N
Yuguchi
M
M
Majima
A
A
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D011412:Propanolamines / Q000009:adverse effects*; D013999:Timolol / Q000009:adverse effects* / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C006034:befunolol; D013999:Timolol